Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS

AIDS

Volumn 11, Issue 4, 1997, Pages 517-524

  D'Arminio Monforte, Antonella ^a   Mainini, Franco ^a   Testa, Letizia ^a   Vago, Luca ^a   Balotta, Livia ^a   Nebuloni, Manuela ^a   Antinori, Spinello ^a   Bini, Teresa ^a   Moroni, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti cytomegalovirus treatments; Relapses and survival; Risk of cytomegalovirus disease

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; HOMOSEXUALITY; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RELAPSE; SURVIVAL;

EID: 0031046891     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00016     Document Type: Article

References (39)

1. Centers for Disease Control: Classification system for human T lymphotropic virus type III/lymphoadenopathy associated virus infection. MMWR 1985, 23:11-16.
2. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 44 (RR-17):19-23.
3. Hoover DR, Saah AJ, Bacellar H, et al.: Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993, 329:1922-1926.
4. Jabs DA, Enger C, Bartlett JG: Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989, 107:75-80.
5. Holland GN, Sidikaro Y, Kreiger AE, et al.: Treatment of Cytomegalovirus retinopathy with GCV. Ophthalmology 1987, 94:815-823.
6. Gross JG, Bozzette SA, Mathews WC, et al.: Longitudinal study of Cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990, 97:681-686.
7. Wilkes MS, Fortin AH, Felix JC, Godwin TA, Thompson WG: Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988, ii:85-88.
8. d'Arminio Monforte A, Vago L, Lazzarin A, et al.: AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS 1992, 6:1159-1164.
9. Centers for Disease Control: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989, 38 (suppl 5):1-9.
10. Rodriguez-Barradas MC, Stool E, Musher DM, et al.: Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis 1996, 23:76 81.
11. Herry I, Cadranel J, Antoine M, et al.: Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS. Clin Infect Dis 1996, 22:612-620.
12. Cinque P, Vago L, Brytting M, et al.: Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992, 166:1408-1411.
13. Gozlan I, Salord JM, Roullet E, et al.: Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992, 166:1416-1421.
14. Wolf D, Spector SA: Diagnosis of cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992, 166:1412-1415.
15. Testa L, d'Arminio Monforte A, Balotta L, et al.: Systemic CMV disease without documented organ involvement in severely immunodepressed patients. Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. Copenhagen, September 1995 [abstract 119].
16. Van Der Bij W, Schirm J, Torensma R, Van Son WJ, Tegzess AM, The TH: Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988, 26:2531-2535.
17. Musicco M, d'Arminio Monforte A, Gasparini M, Mainini F, Moroni M, the Ticata Group: CMV disease in AIDS patients: multicentric randomized Italian study of maintenance therapy. Fourth European Conference on Clinical Aspects and Treament of HIV Infection. Milan, March 1994 [abstract P158].
18. Vago L, Sala E, Nebuloni M, et al.: Coinfection of the central nervous system by cytomegalovirus and herpes simplex viruses type-1 or 2 in AIDS patients; autopsy study on 82 cases by immunohistochemistry and polymerase chain reaction. Acta Neuropathol 1996, 92:404-408.
19. d'Arminio Monforte A, Mainini F, Musicco M, et al.: Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan [letter]. Lancet 1991, 346:1488
20. Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA: The role of initial AIDS-defining illness in survival following AIDS. AIDS 1995, 9:57-63.
21. Gallant JE, Moore RD, Richmann DD, et al.: Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992, 166:1223-1227.
22. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggense L, Murphy R: Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992, 5:1069-1074.
23. d'Arminio Monforte A, Mainini F, Vago L, et al.: Factors associated with increased risk of acquiring cytomegalovirus disease in AIDS patients. J Infect Dis 1993, 168:1071-1072.
24. Brosgart CL, Craig C, Hillman D, et al.: A randomized, placebo-controlled trial of the safety and efficacy of oral GCV for prophylaxis of CMV retinal and gastrointestinal mucosal disease in HIV-infected individuals with severe immunosuppression. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September 1995 [abstract LB-10].
25. Spector SA, McKinley GF, Lalezari JP, et al: Oral GCV for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996, 334:1491-1497.
26. Harb GF, Bacchetti P, Jacobson MA: Survival of patients with AIDS and cytomegalovirus disease treated with GCV or PFA. AIDS 1991, 5:959-965.
27. Jacobson MA, O'Donnell JJ, Brodie HR, et al.: Randomized prospective trial of GCV maintenance therapy for cytomegalovirus retinitis. J Med Virol 1988, 25:339-349.
28. Buhles WC, Mastre BJ, Tinker AJ, et al.: Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis 1988, 10 (suppl 3):S495-S506.
29. Laskin OL, Cederberg DM, Mills J, et al.: Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 1987, 83:201-207.
30. Jacobson MA, O'Donnell JJ, Porteous D, et al.: Retinal and gastrointestinal disease due to cytomegalovirus in patients with acquired immune deficiency syndrome: prevalence, natural history, and response to GCV therapy. Quart J Med 1988, 67:473-486.
31. Jacobson MA, O'Donnell JJ, Mills J: Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother 1989, 33:736-741.
32. Palestine AG, Polis MA, De Smet MD, et al : A randomized, controlled trial of PFA in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991, 115:665-673.
33. Holland GN, Sison RF, Jatulis DE, et al.: Survival of patients with the acquired immunodeficiency syndrome after development of cytomegalovirus retinitis. Ophthalmology 1990, 97:204-211.
34. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either PFA or GCV for cytomegalovirus retinitis. N Engl J Med 1992, 326:213 220.
35. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group: Antiviral effects of PFA and GCV therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995, 172:613-621.
36. Jacobson MA, Van der Horst C, Causey MD, et al.: In vivo additive antiretroviral effect of combined zidovudine and PFA therapy for human immunodeficiency virus infection (ACTG protocol 053). J Infect Dis 1991, 163:1219-1222.
37. Drew WL, Ives D, Lalezari JP, et al.: Oral GCV as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 1995, 333:615-620.
38. Cinque P, Baldanti F, Vago L, et al.: Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV-DNA detection in cerebrospinal fluid. J Infect Dis 1995, 171:1603-1606.
39. Cinque P, Vago L, Dahl H, et al.: Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996, 10:951-958.